Si-Bone (SIBN) Profit After Tax Growth (1y) (2018 - 2026)
Si-Bone (SIBN) Profit After Tax Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 51.30% |
| 10 | Si-Bone | 696.98 Mn | 556.86 Mn | 41.94 Mn | 33.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.75% |
| Dec 31, 2025 | 63.43% |
| Sep 30, 2025 | 30.56% |
| Jun 30, 2025 | 31.18% |
| Mar 31, 2025 | 40.00% |
| Dec 31, 2024 | 59.07% |
| Sep 30, 2024 | 34.39% |
| Jun 30, 2024 | 20.23% |
| Mar 31, 2024 | 1.99% |
| Dec 31, 2023 | 1.72% |
| Sep 30, 2023 | 29.21% |
| Jun 30, 2023 | 39.47% |
| Mar 31, 2023 | 36.10% |
| Dec 31, 2022 | 22.81% |
| Sep 30, 2022 | 10.80% |
| Jun 30, 2022 | -32.42% |
| Mar 31, 2022 | -42.22% |
| Dec 31, 2021 | -61.23% |
| Sep 30, 2021 | -67.53% |
| Jun 30, 2021 | -12.10% |